{"date":"2025-08-12","count":96,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6634-2025-08-12-2105-1v75o42","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"21:05:58","subject":"公告本公司限制員工權利新股收回註銷減資變更登記完成","clause":"第35款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-08-12 21:05，「公告本公司限制員工權利新股收回註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-08-12-1918-xdqyan","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"19:18:37","subject":"公告本公司董事會通過孫公司與Tract Therapeutics, Inc.之合併案","clause":"第9款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-08-12 19:18，「公告本公司董事會通過孫公司與Tract Therapeutics, Inc.之合併案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-08-12-1903-xyhazt","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"19:03:28","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-08-12 19:03，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-08-12-1901-1oxst1n","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"19:01:00","subject":"公告本公司治療退化性關節炎之異體間質幹細胞新藥Chondrochymal之臨床二期試驗取得統計結果(補正次要療效指標統計結果與公司因應措施)","clause":"第8款","fact_date":"2025-07-31","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-08-12 19:01，「公告本公司治療退化性關節炎之異體間質幹細胞新藥Chondrochymal之臨床二期試驗取得統計結果(補正次要療效指標統計」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-08-12-1855-ey7uem","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:55:23","subject":"公告本公司代理發言人與財務主管異動","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-08-12 18:55，「公告本公司代理發言人與財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-08-12-1852-8yq0cv","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:52:12","subject":"公告本公司提報董事會114年第2季財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-08-12 18:52，「公告本公司提報董事會114年第2季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-08-12-1847-b13tnc","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:47:34","subject":"公告本公司稽核主管任命案","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-08-12 18:47，「公告本公司稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2025-08-12-1837-1evq7r1","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"18:37:34","subject":"公告本公司第六屆薪酬委員會成員","clause":"第6款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2025-08-12 18:37，「公告本公司第六屆薪酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2025-08-12-1837-1vjkx0l","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"18:37:13","subject":"公告本公司114年度第2季合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2025-08-12 18:37，「公告本公司114年度第2季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2025-08-12-1835-17bz8mt","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:35:00","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告","clause":"第19款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2025-08-12 18:35，「本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-08-12-1833-isg045","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:33:38","subject":"公告本公司董事長訂定除權息基準日相關事宜","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-08-12 18:33，「公告本公司董事長訂定除權息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-08-12-1820-1s7xzm3","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:20:54","subject":"公告本公司向關係人取得使用權資產","clause":"第17款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-08-12 18:20，「公告本公司向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-08-12-1820-15589nw","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"18:20:35","subject":"公告本公司除權息基準日相關事宜","clause":"第14款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-08-12 18:20，「公告本公司除權息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-08-12-1818-1p7ghxv","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:18:40","subject":"公告本公司董事會決議不分派114年上半年度股利","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-08-12 18:18，「公告本公司董事會決議不分派114年上半年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-08-12-1817-1n5bf15","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"18:17:15","subject":"公告本公司修訂一一四年度員工認股權憑證發行及認股辦法","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-08-12 18:17，「公告本公司修訂一一四年度員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-08-12-1815-1073yz4","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"18:15:16","subject":"公告本公司董事會決議114年上半年度股利分派","clause":"第14款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-08-12 18:15，「公告本公司董事會決議114年上半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-08-12-1814-xyhazt","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:14:43","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-08-12 18:14，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-08-12-1814-1lt5wzb","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:14:12","subject":"公告本公司董事會決議通過公司遷址案","clause":"第44款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-08-12 18:14，「公告本公司董事會決議通過公司遷址案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-08-12-1812-78pb3x","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:12:31","subject":"公告本公司董事會訂定配股基準日","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-08-12 18:12，「公告本公司董事會訂定配股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-08-12-1811-11kuihw","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:11:55","subject":"公告本公司發言人異動追認案","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-08-12 18:11，「公告本公司發言人異動追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-08-12-1811-1vjqj49","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:11:21","subject":"公告本公司財務主管、會計主管及代理發言人異動","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-08-12 18:11，「公告本公司財務主管、會計主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-08-12-1809-5j9o7v","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"18:09:11","subject":"公告本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-08-12 18:09，「公告本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-08-12-1808-1cyiaim","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"18:08:58","subject":"公告本公司董事會決議召開114年股東臨時會","clause":"第32款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-08-12 18:08，「公告本公司董事會決議召開114年股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-08-12-1807-xyhazt","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"18:07:51","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-08-12 18:07，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-12-1758-harfh0","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"17:58:00","subject":"代重要子公司佳醫資產管理事業股份有限公司公告董事會決議除權基準日相關事宜","clause":"第14款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-12 17:58，「代重要子公司佳醫資產管理事業股份有限公司公告董事會決議除權基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-12-1757-zvlmnp","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"17:57:04","subject":"公告本公司董事會解除經理人競業禁止之限制","clause":"第21款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-12 17:57，「公告本公司董事會解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-12-1755-18hrc6i","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"17:55:55","subject":"公告本公司董事會授權董事長訂定除權暨增資基準日及相關事宜","clause":"第51款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-12 17:55，「公告本公司董事會授權董事長訂定除權暨增資基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-12-1754-aa2zln","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"17:54:44","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-12 17:54，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-08-12-1750-1uo0o2e","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"17:50:05","subject":"公告本公司董事會通過變更營業地址","clause":"第51款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-08-12 17:50，「公告本公司董事會通過變更營業地址」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-08-12-1747-1ns4x8o","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:47:53","subject":"本公司114年上半年度財務報表已提報董事會","clause":"第43款","fact_date":"2025-08-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-08-12 17:47，「本公司114年上半年度財務報表已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-08-12-1744-xyhazt","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"17:44:38","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-08-12 17:44，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-08-12-1742-xyhazt","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"17:42:51","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-08-12 17:42，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-08-12-1740-12f70aa","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:40:21","subject":"公告董事會決議114年上半年度股利分派","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-08-12 17:40，「公告董事會決議114年上半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-08-12-1739-1vi9le6","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:39:50","subject":"公告本公司董事會通過114年度第二季財務報表","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-08-12 17:39，「公告本公司董事會通過114年度第二季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-08-12-1739-p67uuk","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:39:27","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-08-12 17:39，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-08-12-1737-18d6nck","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:37:34","subject":"公告本公司董事會決議通過私募普通股補辦公開發行及申請登錄興櫃","clause":"第44款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-08-12 17:37，「公告本公司董事會決議通過私募普通股補辦公開發行及申請登錄興櫃」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-08-12-1735-92wwtj","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:35:05","subject":"公告本公司提報董事會2025年第2季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-08-12 17:35，「公告本公司提報董事會2025年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-08-12-1730-xyhazt","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"17:30:35","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-08-12 17:30，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-08-12-1730-1xtjtmq","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:30:13","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-08-12 17:30，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-08-12-1724-aa2zln","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"17:24:24","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-08-12 17:24，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-08-12-1723-1z0lgo7","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:23:13","subject":"更正本公司114年度第二季合併財務報告附註資訊","clause":"第44款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-08-12 17:23，「更正本公司114年度第二季合併財務報告附註資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-08-12-1716-dj0min","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:16:32","subject":"公告本公司董事會授權董事長訂定除權息暨增資基準日及相關事宜","clause":"第44款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-08-12 17:16，「公告本公司董事會授權董事長訂定除權息暨增資基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-08-12-1713-xyhazt","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:13:00","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-08-12 17:13，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-08-12-1705-c2fkh1","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"17:05:38","subject":"公告本公司背書保證達「資金貸與及背書保證處理準則」第二十五條第一項第四款之規定。","clause":"第22款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-08-12 17:05，「公告本公司背書保證達「資金貸與及背書保證處理準則」第二十五條第一項第四款之規定。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2025-08-12-1703-1xtjtmq","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"17:03:40","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2025-08-12 17:03，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-08-12-1703-jltw2f","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"17:03:09","subject":"公告本公司董事會決議通過經理人之競業禁止解除案","clause":"第21款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-08-12 17:03，「公告本公司董事會決議通過經理人之競業禁止解除案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-08-12-1700-1o2fkq","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"17:00:07","subject":"公告本公司董事會決議訂定除權增資基準日","clause":"第14款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-08-12 17:00，「公告本公司董事會決議訂定除權增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-08-12-1656-aa2zln","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:56:56","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-08-12 16:56，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-08-12-1655-izwgnh","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:55:45","subject":"公告本公司114年7月份自結合併損益","clause":"第53款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-08-12 16:55，「公告本公司114年7月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-12-1654-z6rxem","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:54:31","subject":"公告本公司股票初次上櫃前現金增資發行新股承銷價格","clause":"第44款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-12 16:54，「公告本公司股票初次上櫃前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-08-12-1652-md718y","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:52:55","subject":"本公司董事會通過第二季合併財報","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-08-12 16:52，「本公司董事會通過第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2025-08-12-1646-hl0kx9","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:46:44","subject":"本公司114年第二季財務報告經董事會決議通過","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2025-08-12 16:46，「本公司114年第二季財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-08-12-1635-1uhskx3","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:35:13","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-08-12 16:35，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-08-12-1634-19etk28","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:34:50","subject":"公告本公司董事會通過114年度第二季個別財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-08-12 16:34，「公告本公司董事會通過114年度第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-08-12-1633-3dteg3","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:33:36","subject":"本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-08-12 16:33，「本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-08-12-1628-12rqycb","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:28:02","subject":"公告本公司配合會計師事務所內部輪調更換會計師","clause":"第7款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-08-12 16:28，「公告本公司配合會計師事務所內部輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2025-08-12-1627-1eaiuug","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:27:53","subject":"公告本公司董事會決議委任薪資報酬委員會委員","clause":"第6款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-08-12 16:27，「公告本公司董事會決議委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2025-08-12-1626-xyhazt","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:26:33","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-08-12 16:26，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-08-12-1625-pbsb4a","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:25:19","subject":"公告本公司董事會通過114年第二季合併財報","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-08-12 16:25，「公告本公司董事會通過114年第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-08-12-1621-oz6xyy","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"16:21:44","subject":"公告本公司董事會通過永續發展委員會提升至董事會層級及委任委員","clause":"第6款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-08-12 16:21，「公告本公司董事會通過永續發展委員會提升至董事會層級及委任委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-08-12-1621-xyhazt","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"16:21:19","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-08-12 16:21，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2025-08-12-1621-106r3jb","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"16:21:07","subject":"公告本公司內部稽核主管任命","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2025-08-12 16:21，「公告本公司內部稽核主管任命」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2025-08-12-1620-vo4hw6","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"16:20:58","subject":"公告本公司董事會通過114年上半年度合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2025-08-12 16:20，「公告本公司董事會通過114年上半年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-08-12-1619-4gs1r3","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:19:26","subject":"公告本公司配合會計師事務所內部調整，自民國114年第二季起更換簽證會計師","clause":"第7款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-08-12 16:19，「公告本公司配合會計師事務所內部調整，自民國114年第二季起更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-08-12-1619-140kqs7","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:19:15","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-08-12 16:19，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2025-08-12-1618-4qeg6v","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:18:58","subject":"公告本公司民國114年第二季財務報表業經提報董事會通過","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2025-08-12 16:18，「公告本公司民國114年第二季財務報表業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-08-12-1617-1uhskx3","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:17:50","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"第9款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-08-12 16:17，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-08-12-1610-kcrxyx","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:10:36","subject":"本公司董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-08-12 16:10，「本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-08-12-1610-1ijbmw5","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:10:17","subject":"本公司董事會決議除權除息基準日、調整配股配息率暨可轉換公司債停止轉換期間公告","clause":"第14款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-08-12 16:10，「本公司董事會決議除權除息基準日、調整配股配息率暨可轉換公司債停止轉換期間公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-08-12-1609-tpoxo","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:09:28","subject":"公告本公司國內第五次有擔保轉換公司債到期還本暨終止上櫃事宜","clause":"第53款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-08-12 16:09，「公告本公司國內第五次有擔保轉換公司債到期還本暨終止上櫃事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-08-12-1609-c167pw","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:09:22","subject":"公告本公司114年度第二季財務報告董事會預計召開日期為114年8月20日","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-08-12 16:09，「公告本公司114年度第二季財務報告董事會預計召開日期為114年8月20日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-08-12-1608-1ichup5","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:08:58","subject":"公告本公司國內第四次有擔保轉換公司債到期還本暨終止上櫃事宜","clause":"第53款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-08-12 16:08，「公告本公司國內第四次有擔保轉換公司債到期還本暨終止上櫃事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-08-12-1608-140kqs7","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:08:40","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-08-12 16:08，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2025-08-12-1605-xyhazt","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:05:34","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：合世（1781），2025-08-12 16:05，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-08-12-1604-sxo3j0","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"16:04:16","subject":"代子公司高峰藥品材料股份有限公司公告董事會決議召開114年第1次股東臨時會相關事宜","clause":"第17款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-08-12 16:04，「代子公司高峰藥品材料股份有限公司公告董事會決議召開114年第1次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-08-12-1602-1xtjtmq","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"16:02:16","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-08-12 16:02，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-12-1558-fugqth","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"15:58:14","subject":"代子公司Handa Therapeutics, LLC公告與XsprayPharma AB簽訂專利授權合約，以強化Phyrago產品之專利保護","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-12 15:58，「代子公司Handa Therapeutics, LLC公告與XsprayPharma AB簽訂專利授權合約，以強化Phy」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-08-12-1548-z6mvey","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"15:48:52","subject":"公告本公司提報董事會114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-08-12 15:48，「公告本公司提報董事會114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-12-1546-muluxb","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"15:46:26","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-12 15:46，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2025-08-12-1544-xyhazt","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"15:44:20","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2025-08-12 15:44，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-08-12-1543-b7s8tp","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"15:43:44","subject":"更正本公司114年01-06月資金貸與資訊揭露明細表及114年第一季合併財務報告之附表一","clause":"第53款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-08-12 15:43，「更正本公司114年01-06月資金貸與資訊揭露明細表及114年第一季合併財務報告之附表一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-08-12-1543-vx6gmy","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"15:43:03","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告(更正公告)","clause":"第23款","fact_date":"2025-01-22","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-08-12 15:43，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告(更正公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2025-08-12-1541-15o3w4c","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"15:41:34","subject":"本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2025-08-12 15:41，「本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-08-12-1536-1xtjtmq","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"15:36:50","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-08-12 15:36，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-08-12-1535-1l1z9qy","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-08-12","time":"15:35:46","subject":"公告本公司商務長(資深行銷兼業務副總)新任","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-08-12 15:35，「公告本公司商務長(資深行銷兼業務副總)新任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2025-08-12-1533-1j46v82","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"15:33:26","subject":"公告本公司現金股利除息基準日","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2025-08-12 15:33，「公告本公司現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2025-08-12-1532-tkjvqe","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"15:32:50","subject":"公告本公司董事會決議通過委任公司治理主管","clause":"第11款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2025-08-12 15:32，「公告本公司董事會決議通過委任公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-08-12-1459-1vpjbxf","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"14:59:19","subject":"公告本公司董事會決議除權基準日","clause":"第14款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-08-12 14:59，「公告本公司董事會決議除權基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-08-12-1458-3joqhp","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"14:58:56","subject":"本公司董事會決議通過114年第2季合併財務報告案","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-08-12 14:58，「本公司董事會決議通過114年第2季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-08-12-1445-1r2v28u","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"14:45:08","subject":"公告本公司提報董事會114年第2季合併財務報表","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-08-12 14:45，「公告本公司提報董事會114年第2季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-08-12-1432-109jtcw","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"14:32:15","subject":"本公司受邀參加元大證券舉辦之線上法說會","clause":"第12款","fact_date":"2025-08-13","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-08-12 14:32，「本公司受邀參加元大證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-08-12-1423-e6ntzi","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"14:23:37","subject":"公告台灣神隆股份有限公司舉行114年上半年線上法人說明會","clause":"第12款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-08-12 14:23，「公告台灣神隆股份有限公司舉行114年上半年線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-08-12-1121-1xdmtzf","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"11:21:33","subject":"本公司受邀參加統一證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-21","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-08-12 11:21，「本公司受邀參加統一證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-08-12-1115-w2f525","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"11:15:32","subject":"公告本公司董事會通過114年度第二季合併財務報表","clause":"第31款","fact_date":"2025-08-12","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-08-12 11:15，「公告本公司董事會通過114年度第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-08-12-1009-adhte6","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-08-12","time":"10:09:25","subject":"(更正)公告本公司董事長訂定民國114年第2季盈餘之除息基準日","clause":"第14款","fact_date":"2025-08-11","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-08-12 10:09，「(更正)公告本公司董事長訂定民國114年第2季盈餘之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2025-08-12-0946-10jca0t","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2025-08-12","time":"09:46:56","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2025-08-12 09:46，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}